MICVOTABART
UNII WY25VXP95W

Substance Identification & Data

This profile provides standardized clinical and technical data for Micvotabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WY25VXP95W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2867549-73-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WY25VXP95W
CAS Registry Number
2867549-73-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MICVOTABART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C206941
National Cancer Institute reference terminology for clinical and research data.
INN ID
13004
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Micvotabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MICVOTABART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-445) (VH (HOMO SAPIENS IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.9) (26-33.51-58.97-105)) (1-116) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14, CH2 C81 (CH1 R120>K (213) (117-214), HINGE 1-15 (215-229), CH2 K81>C (289) (230-339), CH3 E12 (355), M14 (357) (340-444), CHS K2>DEL (445)) (117-445)), (219-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-215') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (94.8%) -IGKJ1*01 (100%), CDR-IMGT (7.3.9) (27'-33'.51'-53'.90'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (99.1%) K93>C (184'), KM3 A45.1 (154'), V101 (192') (109'-215')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1 (98-ARGININE,289-CYSTEINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN FIBRONECTIN EXTRA DOMAIN B SPLICE VARIANT) (HUMAN MONOCLONAL PYX-201 .GAMMA.1-CHAIN), DISULFIDE WITH (184-CYSTEINE) HUMAN MONOCLONAL PYX-201 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FN1 (FIBRONECTIN 1) EXTRA DOMAIN B (ED-B) SPLICE VARIANT), HOMO SAPIENS MONOCLONAL ANTIBODY
MICVOTABART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus